Show notes
Discover how human leukocyte antigens (HLAs)—once key to organ transplantation—are now transforming cancer immunotherapy and autoimmune disease treatment. Marcelo Fernandez Vina, Director of the Histocompatibility & Immunogenetics Laboratory at Stanford Blood Center, and Dave Lowe, Senior Director of R&D, Transplant Diagnostics at Thermo Fisher, reveal how this decades-old tool is reshaping modern medicine.


